Percutaneous endoscopic gastrostomy feeding-a life-saving intervention in SSc-myositis overlap with pharyngeal dysfunction

Rheumatology (United Kingdom)

Volumn 51, Issue 8, 2012, Pages 1518-1520

  Das, Leena ^a   Bowden, Andrew ^b   Cooper, Robert G ^a   Mitchell, William ^c   O'sullivan, Margaret ^d   Herrick, Ariane L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Rochdale Infirmary   (United Kingdom)

^c FURNESS GENERAL HOSPITAL   (United Kingdom)

^d BETSI CADWALADR UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ASPIRATION PNEUMONIA; CASE REPORT; DISEASE DURATION; DYSPHAGIA; FEMALE; FLUOROSCOPY; HUMAN; LETTER; LUNG INFILTRATE; LUNG LOBE; MALE; MUSCLE WEAKNESS; MYOSITIS; PALATOPHARYNGEAL INCOMPETENCE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TUBE FEEDING;

DEGLUTITION DISORDERS; ENTERAL NUTRITION; FEMALE; GASTROSTOMY; HUMANS; MALE; MIDDLE AGED; POLYMYOSITIS; SCLERODERMA, SYSTEMIC;

EID: 84865161632     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes020     Document Type: Letter

References (10)

1. LeRoy EC, Black C, Fleischmajer R et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998;15:202-5.
2. Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin N Am 1998;27:563-94.
3. Ioannou Y, Sultan S, Isenberg DA. Myositis overlap syndromes. Curr Opin Rheumatol 1999;11:468-74.
4. Steen VD, Medsger TA Jr, Osial TA Jr et al. Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 1984;76:779.
5. Sjogren RW. Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 1994;37:1265-8.
6. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006;40:769-75.
7. Garrett JM, Winkelmann RK, Schlegel JF et al. Esophageal deterioration in scleroderma. Mayo Clin Proc 1971;46: 92-6.
8. Dantas RO, Meneghelli UG, Oliveira RB et al. Esophageal dysfunction does not always worsen in systemic sclerosis. J Clin Gastroenterol 1993;17:281-5.
9. Bassotti G, Battaglia E, Debernardi V et al. Esophageal dysfunction in scleroderma. Relationship with disease subsets. Arthritis Rheum 1997;40:2252-9.
10. Lock G, Holstege A, Lang B et al. Gastrointestinal manifestations of progressive systemic sclerosis. Am J Gastroenterol 1997;92:763-71.